Collectively, our data show that the clonal composition of EBV-specific CD8 T cells was globally maintained in melanoma patients undergoing TLD and followed by immune reconstitution, despite fluctuations in frequencies within specific patients and for clonotypes detectable at lower frequencies. The gene discussed is CD8A; the disease is melanoma.